Author

Amir Ali Hamidieh

Pediatric Cell & Gene Therapy Research Center, Tehran University of - Cited by 2,892 - Stem Cell Transplantation - Hematology - Oncology - Pediatric Stem Cell Transplant

Biography

I am Amir Ali Hamidieh, belonging to DApplied Cell Sciences department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran, interested in the field of Regenerative medicine.                                         
Title
Cited by
Year
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
D Niederwieser, H Baldomero, N Bazuaye, C Bupp, N Chaudhri, ...Haematologica 107 (5), 1045, 2022202
77
2022
Toward in vitro production of platelet from induced pluripotent stem cells
E Izady, Z Saltanatpour, LP Liu, A Alizadeh, AA HamidiehStem Cell Reviews and Reports 18 (7), 2376-2387, 2022202
4
2022
The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial
M Zarrabi, MG Akbari, M Amanat, A Majmaa, AR Moaiedi, ...BMC neurology 22 (1), 123, 2022202
4
2022
Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
A Rajabzadeh, AA Hamidieh, F RahbarizadehBMC Molecular and Cell Biology 22 (1), 1-9, 2021202
4
2021
Bacterial contamination of bone allografts in the tissue banks: a systematic review and meta-analysis
N Baseri, A Meysamie, F Campanile, AA Hamidieh, A JafarianJournal of Hospital Infection 12, 156-17, 2022202
3
2022
Fludarabine-based reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in a pediatric patient with bone marrow failure syndrome type 3
D Barhoom, R Mohseni, M Behfar, AA HamidiehJournal of Pediatric Hematology/Oncology 44 (8), e1050-e105, 0
2
2022
Development of a bioluminescence assay for BIR2-caspase3 interaction through split luciferase complementary assay
Development of a bioluminescence assay for BIR-caspase3 interaction through split luciferase complementary assayM Mostafavi, F Ataei, AA Hamidieh, S HosseinkhaniBiochemical Engineering Journal 186, 108584, 0
2
2022
Molecular characterization of a large cohort of mucopolysaccharidosis patients: Iran Mucopolysaccharidosis RE‐diagnosis study (IMPRESsion)
SR Ghaffari, M Rafati, M Shadnoush, S Pourbabaee, M Aghighi, ...Human Mutation 43 (4), e1-e3, 0
2
2022
HLA alleles and haplotype frequencies in Iranian population
S Ghafouri-Fard, BM Hussen, S Pashmforoush, MT Akbari, S Arsang-Jang, ...Human Antibodies 30 (), 79-96, 0
2
2022
Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and …
M Esfandbod, M Enshaei, SM Monzavi, M Kabootari, M Behfar, ...Leukemia Research 111, 106703, 010
2
2021
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
M Khoshandam, H Soltaninejad, M Mousazadeh, AA Hamidieh, ...Genes & Diseases, 2023202
1
2023
Menstrual blood-derived mesenchymal stem cell therapy for severe COVID-19 patients
Menstrual blood-derived mesenchymal stem cell therapy for severe COVID-9 patientsF Heidari, MN Sabet, R Heidari, AA Hamidieh, Z SaltanatpourCurrent stem cell research & therapy, 2023202
1
2023
Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMT
Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 207 from APBMTM Iida, K Liu, XJ Huang, W Depei, Y Kuwatsuka, JH Moon, A Dodds, ...Blood Cell Therapy 5 (4), 87, 2022202
1
2022
Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantation
H Namdari, M Hosseini, M Yazdanifar, H Farajifard, F Parvizpour, ...Reviews in Medical Virology 32 (4), e239, 2022202
1
2022
An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients
An open-label phase clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type patientsR Mohseni, AA Hamidieh, A Shoae-Hassani, M Ghahvechi-Akbari, ...Neurological Sciences 43 (), 399-40, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=KcZ0OZkAAAAJ&hl=en

Cited by
Citations 2892
h-index 26
i10-index 74
Recommended Journals
Open Access Journals